Description
It can be used in the treatment of:
Central nervous system: degenerative-involving psychorganic brain syndromes or secondary to cerebrovascular insufficiency, cognitive disorders of the elderly characterized by memory deficits, confusion, disorientation, and reduced attentional capacity, acute and chronic cerebrovasculopathies, head trauma, post-ischemic brain sequelae, Parkinson's disease, Alzheimer's disease.
Visual function: glaucoma, amblyopia, scotomas.
Hearing functions: vertigo, tinnitus, tinnitus.
Citicoline, also known as Citidin5-diphosphocholine or CDP-Choline, is a molecule found in the body. It is physiologically used as a precursor in the endogenous synthesis of nerve cell membrane phospholipids. It represents the biological substrate necessary for the synthesis of acetylcholine and other neurotransmitters, which are essential for the propagation of nerve impulses.
Citicoline plays its biochemical-metabolic role:
Stimulating the biosynthesis of brain phospholipids (phosphatidylcholine, phosphatidylserine, phosphatidylethanolamine).
Increasing synthesis of acetylcholine and other neurotransmitters by increased bioavailability of choline at the neuronal level.
Improving cerebral microcirculatory hemodynamics and increasing cerebral plasma flow.

Ingredients
Citicoline.

Mode of use.
It is recommended to take 1 vial daily, unless otherwise prescribed by a physician.

Conservation
Store at temperatures below 22 °C.
Validity with intact packaging: 36 months.

Format
10 single-dose vials.
Net weight: 100 ml.